| |
|
|
|
|
|
|
|||
|
Prepublished online as a Blood First Edition Paper on March 6, 2003; DOI 10.1182/blood-2002-09-2831.
Blood, 15 July 2003, Vol. 102, No. 2, pp. 731-733 Lack of NB1 GP (CD177/HNA-2a) gene transcription in NB1 GP- neutrophils from NB1 GPexpressing individuals and association of low expression with NB1 gene polymorphismsFrom the Institute for Clinical Immunology and Transfusion Medicine and the Institute for Pathology, University of Giessen, Germany; and the Department of Hematology, University of Marburg, Germany
The human neutrophil NB1 glycoprotein (NB1 GP, HNA-2a, CD177) has gained clinical importance for being involved in pulmonary transfusion reactions and immune neutropenias. The NB1 GP shows the unique feature of being expressed only on a neutrophil subpopulation. Recently, we identified splicing defects responsible for an NB1 GP deficiency. In this study, we have investigated the molecular basis of the heterogeneous expression of NB1 GP by separating the 2 neutrophil subpopulations using immunofluorescence followed by single-cell picking or by fluorescence-activated cell sorter. We found a lack of NB1 mRNA in the NB1 GP- cells that remained constant even after granulocyte colony-stimulating factor (G-CSF) administration. Comparing the cDNA sequences of donors with a large (> 60%) and those with a small (< 40%) NB1 GPexpressing subpopulation, we found 6 polymorphisms. Of the 6, 3 were significantly associated with a small NB1 GPexpressing subpopulation, indicating a genetic basis for NB1 GP nonexpression.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2003 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||